查看購物車
  • English
  • Japanese
  • Korean
介入影像市場－全球及區域分析：按產品、應用、最終使用者、地區和國家分類－分析與預測：2026-2036年
市場調查報告書
商品編碼
2067562

介入影像市場－全球及區域分析：按產品、應用、最終使用者、地區和國家分類－分析與預測：2026-2036年

Interventional Imaging Market - A Global and Regional Analysis: Focus on Product, Application, End User, Regional, and Country - Analysis and Forecast: 2026-2036
出版日期: | 出版商: BIS Research | 英文 122 Pages | 商品交期: 1-5個工作天內

價格

全球介入影像市場在2025年的初始估值為 104.4億美元，但預計將大幅成長，到2036年達到 199.661億美元。

這將使2026年至2036年期間的年複合成長率達到驚人的6.07%。

關鍵市場統計資料
預測期 2026-2036
2026年市場規模 110.691億美元
2036年的預測 199.661億美元
年複合成長率 6.07%

全球介入影像市場正經歷持續成長，這主要得益於循環系統、腫瘤、神經、血管和整形外科等專科領域微創手術的日益普及。介入影像系統透過提供解剖結構、醫療設備和治療標靶的即時視覺化，在指導治療過程中發揮非常重要的作用。透視、血管造影術、電腦斷層掃描（CT）、超音波、磁振造影（MRI）和混合成像平台等技術正日益成為影像引導介入治療的必備工具，使臨床醫生能夠更精準、安全、高效地完成複雜的手術。慢性病盛行率的上升、對微創治療方法需求的成長以及醫院和門診手術中心手術量的增加，都進一步推動了市場的擴張。

技術進步顯著提升了介入影像系統的性能。高解析度3D和4D成像、融合成像、錐狀射束CT、先進導航軟體和即時影像處理等創新技術，在提高手術精度和臨床療效的同時，也縮短了手術時間並減少了輻射暴露。人工智慧、機器人技術和影像引導導航技術的融合進一步最佳化了工作流程，並支援更個人化的介入治療。此外，混合手術室和多學科介入治療中心的建設也推動了對先進診斷影像基礎設施的需求。儘管高成本、監管要求和保險償付方面的挑戰可能會限制某些地區的推廣應用，但持續的創新和影像引導治療作用的不斷擴大有望推動介入成像技術的長期發展，使其成為現代微創醫學的基石。

市場概覽

隨著影像導引手術在醫療保健系統中日益重要，其能夠提高手術精度、減輕患者負擔並縮短復原時間，全球介入影像市場正經歷顯著成長。介入成像技術為臨床醫生在診斷和治療過程中提供即時視覺化，支持包括介入心臟病學、腫瘤治療、神經血管手術和微創手術在內的廣泛應用。隨著手術難度不斷增加，醫療機構正增加對先進影像平台的投資，以實現精準的設備導航、更清晰的解剖結構可視化和無縫的手術引導，有助於改善臨床療效和提高手術效率。

介入影像領域正因診斷影像硬體和軟體的不斷進步而發生變革。諸如3D可視化、影像融合技術、錐狀射束成像、先進導航系統以及更有效率的工作流程整合等技術發展，提高手術精度，並實現臨床資源的更有效率利用。隨著混合手術室和整合介入手術室的日益普及，對能夠在單一環境中支援多個專科的先進診斷影像解決方案的需求也進一步成長。此外，人工智慧、自動化影像處理和機器人輔助技術的引進，提升決策支援和手術規劃能力。儘管高昂的實施成本和基礎設施要求可能會在某些醫療機構中構成應用挑戰，但對微創醫學和技術主導的手術最佳化的日益重視表明，全球介入影像市場將保持長期成長。

對產業的影響

全球介入影像市場對醫療技術產業產生了重大影響，推動了影像導引微創手術在多個臨床專科領域的廣泛應用。GE HealthCare、Siemens Healthineers、Koninklijke Philips N.V.、Canon Medical Systems Corporation、FUJIFILM Holdings Corporation、Shimadzu Corporation、Stryker Corporation等領先製造商不斷開發具有增強的可視化、導航和手術引導功能的介入影像平台。這些創新技術在介入心臟病學、腫瘤學、神經血管手術和血管外科等領域中發揮著非常重要的作用，在這些領域，精準的即時影像對於治療的準確性和病患安全非常重要。 3D視覺化、錐狀射束CT、影像融合和整合導航系統等先進技術幫助臨床醫生完成日益複雜的手術，同時也有助於提高手術效率和改善臨床療效。

從產業角度來看，介入影像技術的演進正推動著醫療模式向「一體化手術生態系統」轉型，該生態系統將影像、導航、軟體分析和治療技術整合於單一臨床環境中。混合手術室和專業介入手術室的日益普及，促使醫療機構投資於能夠支援多種微創手術的多功能影像平台。此外，人工智慧、自動化和機器人輔助技術的引進，改善手術流程的協調、手術規劃以及術中決策。透過降低手術複雜性、支持精準引導治療以及提高手術效率，介入影像系統鞏固現代介入治療的基礎，並推動以患者為中心、技術主導的全球醫療服務模式的進步。

目錄

第1章 全球介入影像市場：產業展望

  • 市場趨勢
    • 影響分析
    • 人工智慧整合
  • 監理情勢
    • 美國
    • 歐洲
    • 亞太地區
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場挑戰
    • 市場機會

第2章 產品

  • 介入性影像系統
    • CT掃描儀
    • X光系統
    • 磁振造影系統
    • 超音波影像系統
  • 介入性影像軟體
  • 消耗品

第3章 應用

  • 循環系統
  • 神經病學
  • 腫瘤學
  • 其他用途

第4章 最終用戶

  • 醫院及門診手術中心
  • 診斷影像中心
  • 其他最終用戶

第5章 區域

  • 區域概況
  • 北美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 美國
      • 加拿大
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 英國
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太其他地區
  • 世界其他地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測

第6章 競爭標竿分析與公司概況

  • 全球介入影像市場：關鍵策略與趨勢，2023年1月至2026年5月
  • 主要發展分析（依公司），2023年1月至2026年5月
  • 公司簡介
    • Boston Scientific Corporation
    • Canon
    • Esaote SPA
    • FUJIFILM Corporation
    • GE Healthcare
    • Koninklijke Philips NV
    • Samsung
    • Siemens Healthineers
    • Shimadzu Corporation
    • Shanghai United Imaging Healthcare Co., LTD
    • Ziehm Imaging GmbH

第7章 調查方法

Product Code: BHR1442SB

This report can be delivered within 1 working day.

Introduction of the Interventional Imaging Market

The global interventional imaging market, initially valued at $10,440.0 million in 2025, is projected to witness substantial growth, reaching $19,966.1 million by 2036, marking a remarkable compound annual growth rate (CAGR) of 6.07% over the period from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$11,069.1 Million
2036 Forecast$19,966.1 Million
CAGR6.07%

The global interventional imaging market is witnessing sustained growth, driven by the increasing adoption of minimally invasive procedures across cardiology, oncology, neurology, vascular, and orthopedic specialties. Interventional imaging systems play a critical role in guiding therapeutic procedures by providing real-time visualization of anatomical structures, medical devices, and treatment targets. Technologies such as fluoroscopy, angiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and hybrid imaging platforms are becoming integral to image-guided interventions, enabling clinicians to perform complex procedures with greater precision, safety, and efficiency. The rising prevalence of chronic diseases, growing demand for minimally invasive treatment options, and increasing procedural volumes in hospitals and ambulatory surgical centers are further supporting market expansion.

Technological advancements are significantly enhancing the capabilities of interventional imaging systems. Innovations such as high-resolution 3D and 4D imaging, fusion imaging, cone-beam CT, advanced navigation software, and real-time image processing are improving procedural accuracy and clinical outcomes while reducing procedure times and radiation exposure. The integration of artificial intelligence, robotics, and image-guided navigation technologies is further streamlining workflow optimization and supporting more personalized interventions. Additionally, the growing development of hybrid operating rooms and multidisciplinary interventional suites is driving demand for advanced imaging infrastructure. Although high equipment costs, regulatory requirements, and reimbursement challenges may limit adoption in certain regions, continuous innovation and the expanding role of image-guided therapies are expected to sustain long-term growth, positioning interventional imaging as a cornerstone of modern minimally invasive healthcare delivery.

Market Introduction

The global interventional imaging market is experiencing significant expansion as healthcare systems increasingly prioritize image-guided procedures that offer improved precision, reduced patient trauma, and shorter recovery times. Interventional imaging technologies provide clinicians with real-time visualization during diagnostic and therapeutic procedures, supporting a broad range of applications in cardiovascular interventions, oncology treatments, neurovascular procedures, and minimally invasive surgeries. As procedural complexity continues to increase, healthcare providers are investing in advanced imaging platforms that enable accurate device navigation, enhanced anatomical visualization, and seamless procedural guidance, helping improve clinical outcomes and procedural efficiency.

Ongoing advancements in imaging hardware and software are transforming the interventional imaging landscape. Developments such as three-dimensional visualization, image fusion techniques, cone-beam imaging, advanced navigation systems, and enhanced workflow integration are enabling greater procedural accuracy while supporting more efficient use of clinical resources. The growing implementation of hybrid operating rooms and integrated interventional suites is further driving demand for sophisticated imaging solutions capable of supporting multiple specialties within a single environment. Additionally, the incorporation of artificial intelligence, automated image processing, and robotic-assisted technologies is enhancing decision support and procedural planning capabilities. While high acquisition costs and infrastructure requirements may present adoption challenges in some healthcare settings, the increasing emphasis on minimally invasive care and technology-driven procedural optimization is expected to sustain long-term growth in the global interventional imaging market.

Industrial Impact

The global interventional imaging market has created a substantial impact on the healthcare technology industry by enabling the widespread adoption of image-guided, minimally invasive procedures across multiple clinical specialties. Leading manufacturers such as GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Shimadzu Corporation, and Stryker Corporation are continuously advancing interventional imaging platforms with enhanced visualization, navigation, and procedural guidance capabilities. These innovations are playing a critical role in areas such as cardiovascular interventions, oncology treatments, neurovascular procedures, and vascular surgery, where precise real-time imaging is essential for treatment accuracy and patient safety. Advanced technologies including 3D visualization, cone-beam CT, image fusion, and integrated navigation systems are helping clinicians perform increasingly complex procedures while improving procedural efficiency and clinical outcomes.

From an industry standpoint, the evolution of interventional imaging is driving a transition toward integrated procedural ecosystems that combine imaging, navigation, software analytics, and therapeutic technologies within a single clinical environment. The growing deployment of hybrid operating rooms and specialized interventional suites is encouraging healthcare providers to invest in multifunctional imaging platforms capable of supporting a broad range of minimally invasive procedures. In addition, the incorporation of artificial intelligence, automation, and robotic-assisted technologies is enhancing workflow coordination, procedural planning, and decision-making during interventions. By reducing procedural complexity, supporting precision-guided therapies, and enabling greater operational efficiency, interventional imaging systems are strengthening the foundation of modern interventional care and contributing to the advancement of patient-centered, technology-driven healthcare delivery worldwide.

Market Segmentation:

Segmentation 1: By Product

  • Interventional Imaging Systems
  • Interventional Imaging Software
  • Consumables

Interventional Imaging Systems Segment to Dominate the Interventional Imaging Market (by Product)

In 2025, interventional imaging systems dominated the market, driven by their essential role in supporting a wide range of minimally invasive diagnostic and therapeutic procedures. These systems provide real-time, high-resolution visualization that enables clinicians to accurately guide catheters, guidewires, implants, and other medical devices during complex interventions. Their extensive use across cardiovascular, neurovascular, oncology, and peripheral vascular procedures has established them as a critical component of modern interventional care. The increasing preference for minimally invasive treatments, which offer reduced hospital stays, lower complication rates, and faster patient recovery, continues to strengthen demand for advanced interventional imaging platforms.

The dominance of interventional imaging systems has been further supported by ongoing technological advancements that enhance procedural precision and workflow efficiency. Features such as three-dimensional imaging, image fusion, cone-beam CT integration, advanced navigation tools, and real-time image processing enable physicians to perform increasingly complex interventions with greater confidence and accuracy. In addition, the expansion of hybrid operating rooms and specialized catheterization laboratories is driving greater adoption of these systems within healthcare facilities. Their ability to support high procedural volumes, accommodate multiple clinical specialties, and improve treatment outcomes positions interventional imaging systems as the leading segment within the global interventional imaging market.

Segmentation 2: By Application

  • Cardiology
  • Neurology
  • Oncology
  • Others

Cardiology Segment to Dominate the Interventional Imaging Market (by Application)

The cardiology segment dominates the interventional imaging market, driven by the high global burden of cardiovascular diseases and the growing volume of image-guided cardiac procedures. Interventional imaging plays a critical role in procedures such as coronary angioplasty, stent placement, transcatheter valve interventions, electrophysiology studies, and structural heart defect repairs, where real-time visualization is essential for accurate device navigation and treatment delivery. The increasing prevalence of conditions such as coronary artery disease, heart failure, and cardiac arrhythmias continues to drive demand for advanced imaging technologies that support precise and minimally invasive cardiac interventions.

The dominance of the cardiology segment has been supported by continuous advancements in cardiovascular imaging technologies, including high-resolution angiography systems, three-dimensional visualization, fusion imaging, and intraprocedural guidance tools. Healthcare providers are increasingly investing in modern catheterization laboratories and hybrid cardiac suites to improve procedural efficiency and patient outcomes. In addition, the growing adoption of minimally invasive cardiovascular treatments, particularly among aging populations and high-risk patients, is contributing to higher procedure volumes worldwide. The combination of strong clinical demand, technological innovation, and expanding interventional cardiology infrastructure positions cardiology as the leading application segment within the global interventional imaging market.

Segmentation 3: By End User

  • Hospital and Ambulatory Surgical Center
  • Diagnostic Imaging Center
  • Others

Hospital and ASC Segment to Dominate the Interventional Imaging Market (by End User)

In 2025, hospitals dominated the interventional imaging market due to their central role in delivering complex diagnostic and therapeutic procedures across multiple specialties. Interventional imaging systems are extensively used in hospital-based catheterization laboratories, operating rooms, and diagnostic suites to support cardiovascular, neurovascular, oncological, and vascular interventions. The availability of advanced infrastructure, skilled interventional specialists, and multidisciplinary care teams enables hospitals to handle high procedural volumes and manage complex cases that require real-time imaging guidance. Additionally, strong capital investment capacity allows hospitals to adopt technologically advanced imaging platforms, further reinforcing their dominant position in the market.

The dominance of ambulatory surgical centers (ASCs) is also growing significantly, driven by the global shift toward minimally invasive and outpatient care. ASCs benefit from cost efficiency, faster patient turnaround times, and streamlined procedural workflows, making them highly suitable for image-guided interventions that do not require prolonged hospitalization. The adoption of compact, high-performance interventional imaging systems in ASCs supports a growing range of same-day procedures, particularly in orthopedics, pain management, and vascular interventions. The rising preference for outpatient care delivery, combined with advancements in portable and user-friendly imaging technologies, is expected to sustain strong growth across both hospitals and ASCs in the interventional imaging market.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Rest-of-the-World

North America to Dominate the Interventional Imaging Market (by Region)

North America dominated the interventional imaging market due to its highly advanced healthcare infrastructure and early adoption of cutting-edge medical imaging technologies. The region is characterized by a strong network of hospitals, academic medical centers, and specialty clinics that routinely perform complex image-guided procedures across cardiology, oncology, neurology, and vascular care. High procedural volumes, coupled with a strong focus on minimally invasive treatments, continue to drive significant demand for advanced interventional imaging systems across the U.S. and Canada.

This market dominance of North America can be attributed to favorable reimbursement frameworks, high healthcare expenditure, and rapid integration of advanced technologies such as hybrid operating rooms, 3D imaging, and AI-assisted navigation systems. The presence of leading global manufacturers and continuous investment in research and development also accelerates the introduction and adoption of innovative imaging solutions in the region. Additionally, strong emphasis on patient safety, procedural efficiency, and value-based healthcare delivery reinforces the widespread utilization of interventional imaging systems, solidifying North America's leading position in the global market.

Recent Developments in the Interventional Imaging Market

  • In November 2025, Canon Medical announced FDA 510(k) clearance for Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, a hybrid angio-CT interventional suite. The platform combines Alphenix Sky+ angiography with Aquilion CT in one room to support diagnosis, planning, treatment, and verification while reducing patient transfer between departments.
  • In March 2026, Philips launched IntraSight Plus, an interventional guidance platform cleared for clinical use in the U.S. and Europe after FDA 510(k) clearance and CE marking. The platform integrates angiography, physiology, IVUS, co-registration, tri-registration, and real-time device visualization to simplify PCI workflows in cath labs.
  • In May 2026, Siemens Healthineers received FDA clearance for six new Artis interventional imaging systems featuring the Optiq AI imaging chain. The portfolio includes floor, ceiling, biplane, and robotic configurations, with AI-based real-time image optimization and deep-learning denoising across fluoroscopy, acquisition, and DSA.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Increasing Burden of Chronic Disease: The growing global burden of chronic diseases has been a major driver accelerating the adoption of interventional imaging technologies. Conditions such as cardiovascular diseases, cancer, diabetes, and chronic respiratory disorders require continuous diagnosis, monitoring, and minimally invasive treatments that rely on advanced imaging modalities including fluoroscopy, CT, MRI, and ultrasound. According to the WHO, non-communicable diseases account for nearly 74% of global deaths, with cardiovascular diseases and cancer being the leading contributors, significantly increasing demand for image-guided procedures. Cardiovascular interventions such as angioplasty, stent placement, TAVR, and electrophysiology procedures depend heavily on real-time fluoroscopic and angiographic imaging for precision and safety, while the rising cancer burden is expanding the use of CT- and ultrasound-guided biopsies and tumor ablation procedures. Increasing diabetes prevalence further drives vascular imaging demand for managing peripheral artery disease and related complications, and the aging population amplifies overall procedure volumes due to higher susceptibility to chronic conditions. Collectively, these factors are strengthening the long-term reliance on interventional imaging across healthcare systems worldwide.

Market Challenges:

High Capital Cost: The high capital investment required for the acquisition, installation, and maintenance of advanced interventional imaging systems remains a key restraint on market growth. Modern platforms such as angiography systems, cone-beam CT units, fluoroscopy systems, and hybrid operating room suites involve substantial upfront costs, often ranging from $500,000 to over $3 million per system, with fully integrated hybrid OR setups reaching up to $8 million depending on configuration and infrastructure requirements. Premium systems from manufacturers such as Siemens Healthineers, GE HealthCare, and Koninklijke Philips N.V., while offering advanced imaging quality, AI integration, and workflow optimization, are typically adopted only by large tertiary-care hospitals and specialized centers with strong capital budgets.

In addition to procurement costs, healthcare providers incur significant recurring expenses for software upgrades, service contracts, calibration, staff training, cybersecurity, and maintenance, with annual service costs accounting for a notable share of total system value. These financial burdens are particularly challenging for small and mid-sized hospitals, ambulatory surgical centers, and facilities in emerging economies, where reimbursement limitations and constrained healthcare budgets restrict adoption. As a result, despite strong clinical benefits, the high total cost of ownership continues to limit widespread penetration of advanced interventional imaging systems globally.

Market Opportunities:

Expansion of Outpatient and Ambulatory Image-Guided Procedures: The shift of minimally invasive procedures from hospitals to ASCs, OBLs, HOPDs, and specialty clinics is creating strong growth opportunities for the interventional imaging market. Advances in imaging technology, procedural techniques, and reimbursement support are enabling more procedures to be performed safely in outpatient settings. This is driving demand for compact, mobile, and cost-efficient imaging systems that do not require fixed angiography infrastructure. Peripheral vascular interventions such as angioplasty, atherectomy, thrombectomy, and stent placement are increasingly performed in outpatient centers, boosting the need for portable fluoroscopy and mobile C-arm systems. Rising procedure volumes in ASCs further highlight the growing preference for decentralized care delivery. Product innovations such as mobile C-arms and portable cone-beam CT systems from companies like GE HealthCare and Koninklijke Philips N.V. are aligned with this trend. Additionally, expanding use of point-of-care ultrasound in outpatient procedures is broadening imaging applications beyond hospitals. Overall, the outpatient shift is significantly expanding the addressable market for interventional imaging solutions.

How can this report add value to an organization?

Product/Innovation Strategy: The interventional imaging market is segmented across modalities such as fluoroscopy, angiography, CT, MRI, ultrasound, and hybrid systems, with growing focus on cardiology, oncology, and neurovascular applications. Innovation is centered on improving real-time visualization, procedural precision, and reducing radiation exposure through advanced imaging technologies. Manufacturers are also prioritizing hybrid operating rooms, mobile imaging platforms, and AI-enabled workflow integration to support evolving clinical needs.

Growth/Marketing Strategy: Market growth is driven by partnerships with hospitals, ambulatory surgical centers, and expanding healthcare networks in emerging regions. Companies are focusing on increasing adoption of mobile imaging systems, hybrid OR solutions, and service-based models including upgrades and training. The shift toward outpatient and minimally invasive care is further accelerating demand for flexible imaging solutions.

Competitive Strategy: The market is highly competitive, with OEMs focusing on superior image quality, real-time guidance, and workflow efficiency. Differentiation is driven by advancements in 3D/4D imaging, cone-beam CT, and AI-assisted navigation technologies. Integration with hospital IT systems and ease of clinical use remain key factors influencing vendor positioning.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global market size estimation, 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including specialty clinics and hospitals, diagnostic laboratories, imaging centers, reference laboratories, and research institutions.
  • The market contribution of Interventional imaging products is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing interventional imaging systems, software and consumables. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and radiography ecosystem, including interventional imaging system manufacturers (OEMs), medical device companies, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, imaging centers, and screening programs have been consulted to validate adoption trends, system-level integration, and clinical utility specific to interventional imaging systems. Respondents, including CEOs, vice presidents, product and marketing directors, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Canon Inc.
  • FUJIFILM Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Samsung
  • Shimadzu Corporation
  • Siemens Healthineers
  • Boston Scientific Corporation
  • Esaote SPA
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Ziehm Imaging GmbH

Table of Contents

Executive Summary

Scope and Definition

1 Global Interventional Imaging Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Impact Analysis
    • 1.1.2 Integration of AI
  • 1.2 Regulatory Landscape
    • 1.2.1 U.S.
    • 1.2.2 Europe
    • 1.2.3 Asia-Pacific
      • 1.2.3.1 China
      • 1.2.3.2 Japan
      • 1.2.3.3 India
      • 1.2.3.4 Other Asia-Pacific Countries with Established and Evolving Regulatory Frameworks
  • 1.3 Market Dynamics
    • 1.3.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.3.2 Market Drivers
      • 1.3.2.1 Rising Prevalence of Chronic Disease
      • 1.3.2.2 Technological Advancement in Imaging Platform
    • 1.3.3 Market Challenges
      • 1.3.3.1 High Capital Cost of Interventional Imaging Systems
    • 1.3.4 Market Opportunities
      • 1.3.4.1 Expansion of Outpatient and Ambulatory Image-Guided Procedures

2 Product

  • 2.1 Interventional Imaging System
    • 2.1.1 CT Scanner
    • 2.1.2 X-Ray Systems
    • 2.1.3 MRI Systems
    • 2.1.4 Ultrasound Imaging Systems
  • 2.2 Interventional Imaging Software
  • 2.3 Consumables

3 Application

  • 3.1 Cardiology
  • 3.2 Neurology
  • 3.3 Oncology
  • 3.4 Other Applications

4 End User

  • 4.1 Hospitals and Ambulatory Surgical Centers
  • 4.2 Diagnostic Imaging Centers
  • 4.3 Other End Users

5 Region

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Market Sizing and Forecast
      • 5.2.4.1 U.S.
        • 5.2.4.1.1 Country Overview
        • 5.2.4.1.2 Driving Factors for Market Growth
        • 5.2.4.1.3 Factors Challenging the Market
        • 5.2.4.1.4 Market Sizing and Forecast
      • 5.2.4.2 Canada
        • 5.2.4.2.1 Country Overview
        • 5.2.4.2.2 Driving Factors for Market Growth
        • 5.2.4.2.3 Factors Challenging the Market
        • 5.2.4.2.4 Market Sizing and Forecast
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Market Sizing and Forecast
      • 5.3.4.1 U.K.
        • 5.3.4.1.1 Country Overview
        • 5.3.4.1.2 Driving Factors for Market Growth
        • 5.3.4.1.3 Factors Challenging the Market
        • 5.3.4.1.4 Market Sizing and Forecast
      • 5.3.4.2 Germany
        • 5.3.4.2.1 Country Overview
        • 5.3.4.2.2 Driving Factors for Market Growth
        • 5.3.4.2.3 Factors Challenging the Market
        • 5.3.4.2.4 Market Sizing and Forecast
      • 5.3.4.3 France
        • 5.3.4.3.1 Country Overview
        • 5.3.4.3.2 Driving Factors for Market Growth
        • 5.3.4.3.3 Factors Challenging the Market
        • 5.3.4.3.4 Market Sizing and Forecast
      • 5.3.4.4 Italy
        • 5.3.4.4.1 Country Overview
        • 5.3.4.4.2 Driving Factors for Market Growth
        • 5.3.4.4.3 Factors Challenging the Market
        • 5.3.4.4.4 Market Sizing and Forecast
      • 5.3.4.5 Spain
        • 5.3.4.5.1 Country Overview
        • 5.3.4.5.2 Driving Factors for Market Growth
        • 5.3.4.5.3 Factors Challenging the Market
        • 5.3.4.5.4 Market Sizing and Forecast
      • 5.3.4.6 Rest-of-the- Europe
        • 5.3.4.6.1 Country Overview
        • 5.3.4.6.2 Driving Factors for Market Growth
        • 5.3.4.6.3 Factors Challenging the Market
        • 5.3.4.6.4 Market Sizing and Forecast
  • 5.4 Asia Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Market Sizing and Forecast
      • 5.4.4.1 China
        • 5.4.4.1.1 Country Overview
        • 5.4.4.1.2 Driving Factors for Market Growth
        • 5.4.4.1.3 Factors Challenging the Market
        • 5.4.4.1.4 Market Sizing and Forecast
      • 5.4.4.2 Japan
        • 5.4.4.2.1 Country Overview
        • 5.4.4.2.2 Driving Factors for Market Growth
        • 5.4.4.2.3 Factors Challenging the Market
        • 5.4.4.2.4 Market Sizing and Forecast
      • 5.4.4.3 India
        • 5.4.4.3.1 Country Overview
        • 5.4.4.3.2 Driving Factors for Market Growth
        • 5.4.4.3.3 Factors Challenging the Market
        • 5.4.4.3.4 Market Sizing and Forecast
      • 5.4.4.4 Australia
        • 5.4.4.4.1 Country Overview
        • 5.4.4.4.2 Driving Factors for Market Growth
        • 5.4.4.4.3 Factors Challenging the Market
        • 5.4.4.4.4 Market Sizing and Forecast
      • 5.4.4.5 South Korea
        • 5.4.4.5.1 Country Overview
        • 5.4.4.5.2 Driving Factors for Market Growth
        • 5.4.4.5.3 Factors Challenging the Market
        • 5.4.4.5.4 Market Sizing and Forecast
      • 5.4.4.6 Rest-of-the-Asia Pacific
        • 5.4.4.6.1 Country Overview
        • 5.4.4.6.2 Driving Factors for Market Growth
        • 5.4.4.6.3 Factors Challenging the Market
        • 5.4.4.6.4 Market Sizing and Forecast
  • 5.5 Rest-of-the-World
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Market Sizing and Forecast

6 Competitive Benchmarking and Company Profiles

  • 6.1 Global Interventional Imaging Market, Key Strategies and Developments, January 2023-May 2026
  • 6.2 Key Developments Analysis (by Company), January 2023-May 2026
  • 6.3 Company Profiles
    • 6.3.1 Boston Scientific Corporation
      • 6.3.1.1 Overview
      • 6.3.1.2 Top Products
      • 6.3.1.3 Top Competitors
      • 6.3.1.4 Key Personnel
      • 6.3.1.5 Analyst View
    • 6.3.2 Canon
      • 6.3.2.1 Overview
      • 6.3.2.2 Top Products
      • 6.3.2.3 Top Competitors
      • 6.3.2.4 Key Personnel
      • 6.3.2.5 Analyst View
    • 6.3.3 Esaote SPA
      • 6.3.3.1 Overview
      • 6.3.3.2 Top Products
      • 6.3.3.3 Top Competitors
      • 6.3.3.4 Key Personnel
      • 6.3.3.5 Analyst View
    • 6.3.4 FUJIFILM Corporation
      • 6.3.4.1 Overview
      • 6.3.4.2 Top Products
      • 6.3.4.3 Top Competitors
      • 6.3.4.4 Key Personnel
      • 6.3.4.5 Analyst View
    • 6.3.5 GE Healthcare
      • 6.3.5.1 Overview
      • 6.3.5.2 Top Products
      • 6.3.5.3 Top Competitors
      • 6.3.5.4 Key Personnel
      • 6.3.5.5 Analyst View
    • 6.3.6 Koninklijke Philips N.V.
      • 6.3.6.1 Overview
      • 6.3.6.2 Top Products
      • 6.3.6.3 Top Competitors
      • 6.3.6.4 Key Personnel
      • 6.3.6.5 Analyst View
    • 6.3.7 Samsung
      • 6.3.7.1 Overview
      • 6.3.7.2 Top Products
      • 6.3.7.3 Top Competitors
      • 6.3.7.4 Key Personnel
      • 6.3.7.5 Analyst View
    • 6.3.8 Siemens Healthineers
      • 6.3.8.1 Overview
      • 6.3.8.2 Top Products
      • 6.3.8.3 Top Competitors
      • 6.3.8.4 Key Personnel
      • 6.3.8.5 Analyst View
    • 6.3.9 Shimadzu Corporation
      • 6.3.9.1 Overview
      • 6.3.9.2 Top Products
      • 6.3.9.3 Top Competitors
      • 6.3.9.4 Key Personnel
      • 6.3.9.5 Analyst View
    • 6.3.10 Shanghai United Imaging Healthcare Co., LTD
      • 6.3.10.1 Overview
      • 6.3.10.2 Top Products
      • 6.3.10.3 Top Competitors
      • 6.3.10.4 Key Personnel
      • 6.3.10.5 Analyst View
    • 6.3.11 Ziehm Imaging GmbH
      • 6.3.11.1 Overview
      • 6.3.11.2 Top Products
      • 6.3.11.3 Top Competitors
      • 6.3.11.4 Key Personnel
      • 6.3.11.5 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Interventional Imaging Market (by Scenario), $Million, 2025, 2026, and 2036
  • Figure 2: Global Interventional Imaging Market, 2025 and 2036
  • Figure 3: Global Interventional Imaging Market (by Country), $Million, 2025
  • Figure 4: Global Interventional Imaging Market Snapshot
  • Figure 5: Global Interventional Imaging Market, $Million, 2025 and 2036
  • Figure 6: Interventional Imaging Market (by Product), $Million, 2025, 2030, and 2036
  • Figure 7: Interventional Imaging Market (by Application), $Million, 2025, 2030, and 2036
  • Figure 8: Interventional Imaging Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 9: Global Interventional Imaging Market (by Product), $Million, 2025, 2030, and 2036
  • Figure 10: Global Interventional Imaging Market (Interventional Imaging System), $Million, 2024-2036
  • Figure 11: Global Interventional Imaging Market (Interventional Imaging System)(CT Scanner), $Million, 2024-2036
  • Figure 12: Global Interventional Imaging Market (Interventional Imaging System)(X-Ray Systems), $Million, 2024-2036
  • Figure 13: Global Interventional Imaging Market (Interventional Imaging System)(MRI Systems), $Million, 2024-2036
  • Figure 14: Global Interventional Imaging Market (Interventional Imaging System)(Ultrasound Imaging Systems), $Million, 2024-2036
  • Figure 15: Global Interventional Imaging Market (Interventional Imaging Software), $Million, 2024-2036
  • Figure 16: Global Interventional Imaging Market (Consumables), $Million, 2024-2036
  • Figure 17: Global Interventional Imaging Market(by Application), $Million, 2025, 2030, and 2036
  • Figure 18: Global Interventional Imaging Market (Cardiology), $Million, 2024-2036
  • Figure 19: Global Interventional Imaging Market (Neurology), $Million, 2024-2036
  • Figure 20: Global Interventional Imaging Market (Oncology), $Million, 2024-2036
  • Figure 21: Global Interventional Imaging Market (Other Applications), $Million, 2024-2036
  • Figure 22: Global Interventional Imaging Market(by End User), $Million, 2025, 2030, and 2036
  • Figure 23: Global Interventional Imaging Market (Hospitals and Ambulatory Surgical Centers), $Million, 2024-2036
  • Figure 24: Global Interventional Imaging Market (Diagnostic Imaging Centers), $Million, 2024-2036
  • Figure 25: Global Interventional Imaging Market (Other End Users), $Million, 2024-2036
  • Figure 26: North America Interventional Imaging Market, $Million, 2024-2036
  • Figure 27: U.S. Digital Interventional Imaging Market, $Million, 2024-2036
  • Figure 28: Canada Interventional Imaging Market, $Million, 2024-2036
  • Figure 29: Europe Interventional Imaging Market, $Million, 2024-2036
  • Figure 30: U.K. Interventional Imaging MarketInterventional Imaging Market, $Million, 2024-2036
  • Figure 31: Germany Interventional Imaging MarketInterventional Imaging Market, $Million, 2024-2036
  • Figure 32: France Interventional Imaging Market, $Million, 2024-2036
  • Figure 33: Italy Interventional Imaging Market, $Million, 2024-2036
  • Figure 34: Spain Interventional Imaging Market, $Million, 2024-2036
  • Figure 35: Rest-of-Europe Interventional Imaging Market, $Million, 2024-2036
  • Figure 36: Asia-Pacific Interventional Imaging Market, $Million, 2024-2036
  • Figure 37: China Interventional Imaging Market, $Million, 2024-2036
  • Figure 38: Japan Interventional Imaging Market, $Million, 2024-2036
  • Figure 39: India Interventional Imaging Market, $Million, 2024-2036
  • Figure 40: Australia Interventional Imaging Market, $Million, 2024-2036
  • Figure 41: South Korea Interventional Imaging MarketMarket, $Million, 2024-2036
  • Figure 42: Rest-of-Asia-Pacific Interventional Imaging Market, $Million, 2024-2036
  • Figure 43: Rest-of-the-World Interventional Imaging Market, $Million, 2024-2036
  • Figure 44: Global Interventional Imaging Market, Key Strategies and Developments, January 2023-May 2026
  • Figure 45: Data Triangulation
  • Figure 46: Top-Down and Bottom-Up Approach
  • Figure 47: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Interventional Imaging Market (by Region), $Million, 2024-2036
  • Table 3: Global Interventional Imaging Market, Key Strategies and Developments (by Company), January 2023-May 2026